CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematopoietic malignancy with few molecular alterations showing a consensual prognostic value. CRLF2 overexpression was recently identified in high-risk T-ALL patients. For these cases, no genomic abnormality was found to be associated wit...
Main Authors: | Maciel, ALT, Poubel, CP, Noronha, EP, Pombo-de-Oliveira, MS, Braga Mansur, M, Emerenciano, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2019
|
Similar Items
-
Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia
by: Elda Pereira Noronha, et al.
Published: (2023-04-01) -
TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia
by: Hossam R. Alkashgari, et al.
Published: (2022-12-01) -
P344: ONCOGENESIS OF CRLF2 OVEREXPRESSION AND EFFECT OF A NOVEL JAK2 INHIBITOR IN CRLF2 OVEREXPRESSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
by: Yan Gu, et al.
Published: (2023-08-01) -
A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report
by: Barbosa, TC, et al.
Published: (2018) -
Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach
by: José Vicente Gil, et al.
Published: (2024-02-01)